Evidence map›Paper›PMID 40986290›Full record

ArticleJournal of Alzheimer's disease : JAD2025

Written picture descriptions distinguish variants of primary progressive aphasia.

Donna C Tippett, Katelyn Surrao, Kyriaki Neophytou, Hana Kim, Jessica Gallegos, Charalambos Themistocleous, Brenda Rapp, Argye E Hillis, Kyrana Tsapkini

Abstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Donna C TippettDepartment of Physical Medicine and Rehabilitation, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0001-9485-9745
Katelyn SurraoDepartment of Physical Medicine and Rehabilitation, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Kyriaki NeophytouDepartment of Physical Medicine and Rehabilitation, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0002-1213-7640
Hana KimDepartment of Communication Sciences and Disorders, University of South Florida, Tampa, FL, USA.ORCID 0000-0002-4183-4867
Jessica GallegosDepartment of Physical Medicine and Rehabilitation, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Charalambos ThemistocleousDepartment of Special Needs Education, University of Oslo, Oslo, Norway.ORCID 0000-0002-9138-0939
Brenda RappDepartment of Cognitive Science, Johns Hopkins University, Baltimore, MD, USA.ORCID 0000-0002-3462-3826
Argye E HillisDepartment of Physical Medicine and Rehabilitation, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0002-5192-1171
Kyrana TsapkiniDepartment of Physical Medicine and Rehabilitation, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0001-6020-5532

Funding

Neural Basis of Lexical Deficits in Hyperacute StrokeR01DC005375 · NIDCD · JOHNS HOPKINS UNIVERSITY · PI Argye E. Hillis · 2002 to 2026
$11.8M
Phase II clinical trial of transcranial direct current stimulation in the treatment of primary progressive aphasiaR01AG075111 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Roy H Hamilton, Kyrana Tsapkini · 2022 to 2026
$6.7M
Targeting language-specific and executive-control networks with transcranial direct current stimulation in aphasic ADR01AG075404 · NIA · JOHNS HOPKINS UNIVERSITY · PI Kyrana Tsapkini · 2022 to 2026
$4.0M
Transcranial direct current stimulation in typical and atypical Alzheimer's diseaseR01AG068881 · NIA · JOHNS HOPKINS UNIVERSITY · PI TSAPKINI, KYRANA · 2020 to 2024
$3.8M
NIA NIH HHS R01 AG068881NIA NIH HHS R01 AG075111NIA NIH HHS R01 AG075404NIDCD NIH HHS R01 DC005375
6 · The paper itself

Abstract

BackgroundFew studies have examined written discourse in primary progressive aphasia (PPA), a clinical syndrome due to frontotemporal lobar degeneration (FTLD) or Alzheimer's disease (AD).ObjectiveWe aim to: (1) determine differences in written discourse in PPA variants and controls using three approaches for analyzing narratives, and (2) make recommendations regarding the clinical utility of these approaches.MethodsIndividuals with PPA and healthy controls wrote descriptions of the Boston Diagnostic Aphasia Examination Cookie Theft Picture (CTP). We hypothesized that written narratives would be characterized by: (1) fewer total words, lower percentages of CTP content units (CUs) and Core Lexicon Words, and lower communication efficiency in all PPA variants compared to controls; (2) fewer content words in semantic variant PPA (svPPA) than in logopenic variant PPA (lvPPA), nonfluent variant PPA (nfvPPA), and controls; and (3) fewer function words in nfvPPA than in lvPPA and controls.ResultsParticipants with svPPA had significantly lower percentages of total CTP CUs, CTP noun and verb phrase CUs, and Core Lexicon Words than lvPPA. Overall content unit (CU) profile of lvPPA was more similar to controls than to the other two variants. Written narratives of participants with nfvPPA and svPPA had significantly lower percentages of particles, a class of function words, than lvPPA participants.ConclusionsPart of speech analysis showed a deficit in function words in nfvPPA. Content unit analysis distinguished svPPA and lvPPA, and is easily incorporated into the clinical environment when spoken data are scarce or difficult to obtain because of speech production impairments.

Indexed as

Aphasia, Primary ProgressiveWritingAgedAged, 80 and overFemaleHumansLanguage TestsMaleMiddle AgedNarrationNeuropsychological TestsSemanticsAlzheimer's diseaseconnected speechcontent unitsdiscoursefrontotemporal dementiaprimary progressive aphasiaspontaneous speech

Identifiers

PMID40986290
PMCPMC12527030

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.